Lumbard & Kellner, LLC Takeda Pharmaceutical CO LTD Transaction History

Lumbard & Kellner, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$12.42 - $15.62 $14,928 - $18,775	-1,202 Reduced 0.95%	125,744 $1.96 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $33,932 - $75,951	-2,651 Reduced 2.05%	126,946 $1.65 Million
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $38,297 - $43,872	-2,919 Reduced 2.2%	129,597 $1.82 Million
Q4 2021 Feb 18, 2022	SELL	$13.17 - $16.4 $55,011 - $68,502	-4,177 Reduced 3.06%	132,516 $1.92 Million
Q3 2021 Nov 18, 2021	SELL	$16.3 - $17.26 $17,212 - $18,226	-1,056 Reduced 0.77%	136,693 $2.24 Million
Q2 2021 Aug 26, 2021	BUY	$16.55 - $18.64 $36,393 - $40,989	2,199 Added 1.62%	137,749 $2.32 Million
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $13,835 - $16,477	-828 Reduced 0.61%	135,550 $2.26 Million
Q4 2020 Feb 11, 2021	SELL	$15.39 - $18.97 $16,190 - $19,956	-1,052 Reduced 0.77%	136,378 $2.4 Million
Q3 2020 Nov 13, 2020	BUY	$17.1 - $19.19 $250,429 - $281,037	14,645 Added 11.93%	137,430 $2.12 Million
Q2 2020 Aug 28, 2020	SELL	$14.59 - $19.5 $82,229 - $109,902	-5,636 Reduced 4.39%	122,785 $2.2 Million
Q1 2020 May 13, 2020	SELL	$13.02 - $20.31 $64,852 - $101,164	-4,981 Reduced 3.73%	128,421 $1.95 Million
Q4 2019 Feb 21, 2020	SELL	$16.88 - $20.83 $6,785 - $8,373	-402 Reduced 0.3%	133,402 $2.63 Million
Q2 2019 Aug 06, 2019	SELL	$16.58 - $20.49 $2,918 - $3,606	-176 Reduced 0.13%	133,804 $2.37 Million
Q1 2019 May 28, 2019	BUY	$16.7 - $21.52 $2.24 Million - $2.88 Million	133,980 New	133,980 $2.73 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Lumbard & Kellner, LLC, based on Form 13F filings with the SEC.

Stay updated on Lumbard & Kellner, LLC with notifications on news.